News and Events
Find out all about our latest news and also what industry events we will be attending in the coming months via the links below.
Latest News
-
CARBOGEN AMCIS Announces Two Successful FDA Inspections at Its Manufacturing Sites in Neuland and Aarau, Switzerland
BUBENDORF, Switzerland (July 22, 2024) —Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of U.S. Food and Drug Administration (FDA) inspections at its Neuland and Aarau sites.24 July 2024 -
CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
BUBENDORF, Switzerland (19 March 2024) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai.19 March 2024 -
CARBOGEN AMCIS Manchester wins prestigious Chemical Industry Award for world-class manufacturing performance
Manchester, UK (20 June 2023) – CARBOGEN AMCIS Manchester, a member of the Switzerland-based CARBOGEN AMCIS Group, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, won the Manufacturing and Resource Efficiency Award at the prestigious Chemistry Industry Awards last week.20 June 2023 -
CARBOGEN AMCIS announces successful FDA and Swissmedic inspections of its facilities in Switzerland
BUBENDORF, Switzerland (02 June 2023) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the completion of a U.S. Food and Drug Administration (FDA) inspection at its headquarters in Bubendorf, Switzerland and a Swissmedic routine inspection at Bubendorf, Aarau and Neuland, Switzerland.02 June 2023 -
CARBOGEN AMCIS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France
Bubendorf, Switzerland (3 February 2023) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has opened a state-of-the-art facility in Saint-Beauzire, France.03 February 2023 -
CARBOGEN AMCIS announces successful Swissmedic inspection at Vionnaz, Switzerland
29 September 2022 -
CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland
BUBENDORF, Switzerland (October 11th, 2017) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today that its Bubendorf, Switzerland API manufacturing site has successfully completed a routine U.S. Food and Drug Administration (FDA) inspection. -
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection
BUBENDORF, Switzerland (July 21st, 2017) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced the renewal of cGMP certificates, and the successful completion of Swissmedic inspections at three of its sites. -
Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS
AHMEDABAD, INDIA, August 11, 2016 – Dishman Pharmaceuticals and Chemicals Ltd (DPCL), leading outsourcing partner for the global pharmaceutical industry, today marked the 10-year anniversary of its acquisition of CARBOGEN AMCIS. A significant milestone of growth and development of Indian-Swiss business relations. -
CARBOGEN AMCIS Sites at Aarau and Neuland in Switzerland Successfully Pass FDA Inspection
BUBENDORF, Switzerland (July 13th, 2016) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced, after reception of the Establishment Inspection Report (EIR), that two of its Swiss sites have successfully completed a U.S. Food and Drug Administration (FDA) inspection.
Upcoming Events
Clear
Search
BIO Asia Taiwan
Taipei Nangang Exhibition Center, Hall 1
L723
25/07/2024 to 28/07/2024
ChemOutsourcing
Parsippany Hilton, Parsippany, NJ
Booth 14
04/09/2024 to 06/09/2024
Bio Japan 2024
PACIFICO Yokohama, Yokohama, Kanagawa, Japan
SWISS Pavilion
09/10/2024 to 11/10/2024
AAPS PharmSci 360
Salt Palace Convention Center, Salt Lake City, UT
Booth #2445
21/10/2024 to 23/10/2024
Access Our Media Kit
About Us
Logo & Media Library
Subscribe to our mailing list for the latest news updates
Join over 4,000 people who already receive news updates from us